Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men
Background—Obesity has been associated with low testosterone (T) in adult males and in pubertal boys. Therapy for hypogonadism with exogenous T may lead to testicular atrophy and later infertility. Only a few studies have demonstrated that the Selective Estrogen Receptor Modulator (SERM) clomiphene citrate (CC), an estrogen receptor antagonist, increases T in obese hypogonadal men while preventing testicular atrophy. No studies to date using CC have been done in younger obese post-pubertal hypogonadal males. Objective—To determine whether CC therapy is effective in increasing serum T levels in hypogonadal post-pubertal obese males 18-21 years. Materials and Methods—A retrospective chart analysis of records in obese men aged 18-21 years was done. Patients with early morning T level
Digital Commons Citation
Bendre, S V.; Murray, P J.; and Basaria, S, "Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men" (2015). Clinical and Translational Science Institute. 323.